Veterinary Medicines

NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Rabies virus, strain Pasteur RIV, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
Download as PDF

Product identification

Medicine name:
NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Rabies virus, strain Pasteur RIV, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain Pasteur RIV, Inactivated
    3.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
    40.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
    40.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 27950/97/Κ2520/27-1-1998/K-0076101
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."